Recombinant Human IL-1ERR (carrier-free) 10 microg and 4 more items

The University of Virginia awarded a contract to Quartzy on August 28, 2026, under purchase order A207_PO-0474615 for the procurement of laboratory reagents and biological materials. The contract, valued at $3,576.81, encompasses five distinct line items of recombinant proteins and cell culture reagents to be delivered to Mary Grachus Harp. The supplies include two units each of Thy 1 (Recombinant Leukocyte Antigen) with human Fc (Fragment crystallizable) region at $619.23 per unit, one unit of Recombinant Human Interleukin-1 Receptor Antagonist (IL-1ERR) carrier-free formulation at $455.00, and one unit of Tumor Necrosis Factor-alpha (TNF-alpha) recombinant protein expressed in HEK 293 cells at $474.99.

The final line item comprises ten units of BioReagent Trypsin-EDTA Solution at $16.99 per unit, a standard enzymatic reagent used for cell dissociation in cell culture applications. All materials specified are suitable for in vitro cell culture work and are classified as sterile, research-grade reagents. The contract represents a one-time procurement of biological research materials with no identified period of performance beyond the award date of August 28, 2026, and no subsequent annual value or renewal terms specified in the contract documentation.